Labor Market Pulse · Life Sciences · September 2026
Life Sciences Labor Market Report: Charlotte-Gastonia-Concord, NC-SC MSA — September 2026
Charlotte's regulatory pay surge outpaces a cooling metro market.
Charlotte Regulatory Affairs Specialist pay climbed to a $117,917 median against a flat $104,000 nationally, even as metro unemployment held at 3.7% and statewide manufacturing shed over 11,000 jobs.
Free archive edition. Published by WageScape as sent to subscribers; data as of September 2026.
Key indicators
- Metro unemployment rate: 3.7% — vs 4.1% national, 11th among large metros
- Regulatory Affairs pay, metro vs. national: $117,917 — vs $104,000 national, up significantly locally
- NC manufacturing payroll change: -11,600 jobs — Jan 2025 to Jan 2026, statewide
- Life sciences manufacturing employment, NC: 34,800+ — Up from zero in 1974; expansion continuing
Key takeaways
Charlotte regulatory pay has pulled ahead of the national market.
Regulatory Affairs Specialist advertised pay rose significantly to $117,917 locally versus a stable $104,000 nationally, consistent with the NC Life Sciences Organization's September forum flagging regulatory and specialized talent as the binding constraint on expansion. Retention plans built on national benchmarks likely understate what it now takes to hold this talent in-market.
Biomanufacturing growth is outrunning the specialized talent pipeline.
BioWork graduates are filling entry-level operator roles at J&J and Fresenius Kabi for roughly $67,000, but that pipeline does not touch CMC, quality, or regulatory leadership — the roles the NC Life Sciences forum identified as the real workforce gap. Headcount plans tied to Amgen or J&J timelines should separate operator staffing from specialized hiring, which will move on a much slower, more expensive track.
Statewide wage softening has not reached life sciences roles.
NC average weekly wages actually declined 0.3% year-over-year and overall wage growth has slowed from 2022 peaks, yet Biostatistician ($140,364) and Clinical Research Associate ($83,636) advertised pay both rose significantly locally. Compensation strategy should treat life sciences as running on a different cycle than the broader metro labor market, not extrapolate from general wage trend data.
CDMO consolidation is quietly reshaping the outsource calculus.
Kincellis Advanced Therapies' leadership consolidation post-merger, paired with sustained CDMO/CMC capacity investment nationally, suggests contract manufacturing options are maturing faster than internal specialized hiring in cell and gene therapy. Build-vs-outsource reviews for CMC-heavy programs may find the outsourcing path has gotten more credible in just the past two quarters.
Median advertised pay by role — Charlotte-Gastonia-Concord, NC-SC MSA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist | $119,058 | $123,500 | $123,500 | Moderate increase | $131,354 |
| Clinical Research Associate | $54,307 | $83,636 | $101,451 | Significant increase | $90,956 |
| Lab Technician | $46,113 | $56,836 | $60,250 | Moderate decline | $47,402 |
| Regulatory Affairs Specialist | $70,009 | $117,917 | $119,783 | Significant increase | $104,000 |
| Clinical Data Manager | $118,202 | $118,202 | $118,203 | Stable | $123,031 |
| Biostatistician | $99,644 | $140,364 | $155,252 | Significant increase | $133,322 |
| Validation Engineer | $80,481 | $96,700 | $102,046 | Significant increase | $108,377 |
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Charlotte metro unemployment held at 3.7% in August, tighter than the national 4.1% but reflecting a hiring pace that cooled to roughly 1,200 jobs per month as manufacturing payrolls statewide shed more than 11,000 positions over the past year. Life sciences stands apart from that softening — Amgen's $1B Holly Springs expansion and J&J's $2B Wilson County biologics campus are adding hundreds of manufacturing jobs even as regional IT and traditional manufacturing retrench, concentrating competition for credentialed talent in a narrow set of biomanufacturing corridors.
What it means
Metro-level tightness masks a bifurcated market: entry-level biomanufacturing operators are being supplied at scale through programs like Wilson Community College's BioWork pipeline, while specialized scientific, quality, and regulatory talent remains acutely scarce — advertised pay for Regulatory Affairs Specialists in Charlotte has risen sharply to a median of $117,917, actually outpacing the national figure. Organizations planning headcount around the Amgen and J&J expansions should expect operator-level roles to fill relatively efficiently but should budget longer timelines and premium compensation for CMC, quality, and regulatory leadership; current conditions suggest reviewing build-vs-outsource assumptions for specialized functions where local CDMO capacity (including recent CDMO consolidation activity) may offer faster time-to-capability than internal hiring.
Looking ahead
Worth watching: NC Life Sciences Organization's workforce findings from its September 23 forum should surface more granular data on biomanufacturing capacity gaps over the next month. Watch for signals on which specialized functions — not just headcount totals — face the longest fill times.
Emerging pressure point: Healthcare accounted for 13 of NC's 2026 WARN notices and 1,455 affected workers, a segment adjacent to clinical and quality talent pools. Monitor whether any of that displaced talent migrates into life sciences clinical operations roles in the Charlotte corridor.
Potential inflection point: Statewide manufacturing payrolls have fallen over 11,000 positions in a year even as Amgen and J&J ramp Charlotte-area and Wilson County biomanufacturing hiring. A 60-day window should clarify whether displaced traditional manufacturing workers are a viable, trainable source for entry-level biomanufacturing roles.
Early indicator: Validation Engineer advertised pay rose significantly locally to $96,700, tracking national biologics manufacturing investment. Sustained movement here would confirm Charlotte is absorbing part of the national GLP-1 and biologics capacity buildout rather than losing it to larger hubs.
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.